Valeant Pharmaceutical

Valeant Pharma ( Bausch & Lomb ) / To cut 10-15 percent jobs

Canada’s Valeant Pharmaceuticals International Inc (VRX.TO: Quote) (VRX.N: Quote), which has offered to buy Bausch & Lomb Holdings for $8.7 billion, said it may slash 10 to 15 percent of the combined company’s workforce. Valeant, which expects to get regulatory nod by early August, said severance plans for the United States and Canada have been … Continue reading →